NASDAQ$CGC
Canopy Growth Corp · Q1 2026 earnings
Q1 2026 earnings · · Before market open · Investor relations
Briefing
Canopy Growth reported Q1 2026, revenue of $145M, net loss of $85M, diluted EPS of $-0.12.
For Q1 2026, Canopy Growth reported revenue of $145M, a net loss of $85M, diluted EPS was $-0.12. Management discusses operating trends, capital, and sector risks in the quarterly filing.
- Revenue $145M.
- Net loss $85M.
- Diluted EPS $-0.12.
- Canopy Growth MD&A highlights liquidity, capital, and core trends.
- Segment and macro factors shape year-over-year comparisons.
Headline financials
Revenue & EPS history
Canopy Growth · Revenue · Quarterly
C$72.1M
Forward guidance
Clinical-stage and growth biotech discuss trial milestones, cash runway, and partnership optionality.
Tailwinds
- Pipeline progress and data readouts.
- Cash runway from recent financings.
- Licensing or collaboration potential.
Headwinds
- Trial failure or regulatory delays.
- Dilution from equity raises.
- Commercialization timing uncertainty.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2026
-1.0%
Avg return
Earnings day
+0.5%
Avg return
5 days after
-2.6%
Avg return
30 days after
47%
23 / 49 earnings
Positive
+25.6%
Q1 2019
Best reaction
-27.3%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | +0.0% | -3.7% | — | |
| Q3 2026 | +1.9% | -0.9% | -0.9% | |
| Q2 2026 | +7.5% | +9.2% | +5.5% | |
| Q1 2026 | +19.6% | +56.2% | +39.0% | |
| Q4 2025 | -23.7% | -24.0% | -28.7% | |
| Q3 2025 | -27.3% | -35.6% | -57.9% | |
| Q2 2025 | -11.2% | -13.4% | -20.9% | |
| Q1 2025 | -8.2% | -1.2% | -35.3% | |
| Q4 2024 | +2.2% | +4.4% | -25.4% | |
| Q3 2024 | -7.5% | -14.4% | -25.8% | |
| Q2 2024 | -10.3% | -8.4% | +37.7% | |
| Q1 2024 | -7.9% | -15.1% | +98.7% | |
| Q4 2023 | -13.7% | -21.0% | -35.5% | |
| Q3 2023 | -16.8% | -15.3% | -25.2% | |
| Q2 2023 | +19.1% | +32.5% | -10.3% | |
| Q1 2023 | +13.5% | +13.8% | +19.7% | |
| Q4 2022 | -10.5% | -15.1% | -32.1% | |
| Q3 2022 | +14.8% | +9.5% | -20.9% | |
| Q2 2022 | -2.1% | -1.1% | -24.7% | |
| Q1 2022 | -0.2% | -1.4% | -11.3% | |
| Q4 2021 | -2.0% | -7.1% | -8.2% | |
| Q3 2021 | +18.9% | -8.1% | -21.9% | |
| Q2 2021 | +0.9% | +4.0% | +15.7% | |
| Q1 2021 | +1.9% | +3.4% | -1.6% | |
| Q4 2020 | -24.1% | -23.7% | -26.6% | |
| Q3 2020 | +12.4% | +11.5% | -44.0% | |
| Q2 2020 | -17.1% | -17.2% | +11.8% | |
| Q1 2020 | -20.1% | +7.2% | -16.0% | |
| Q4 2019 | -6.1% | -7.0% | -17.0% | |
| Q3 2019 | +3.3% | +0.7% | -0.3% | |
| Q2 2019 | -8.2% | -14.8% | -19.6% | |
| Q2 2018 | +0.4% | -2.4% | -24.3% | |
| Q1 2019 | +25.6% | +52.5% | +91.7% | |
| Q4 2018 | -1.0% | -0.5% | -17.1% | |
| Q3 2017 | +9.4% | +15.8% | +4.6% | |
| Q2 2017 | +5.2% | +17.3% | +38.4% | |
| Q1 2017 | +1.9% | +1.0% | +19.5% | |
| Q4 2017 | -2.6% | -4.4% | -14.9% | |
| Q3 2016 | +2.6% | +9.7% | +9.6% | |
| Q2 2016 | +6.1% | +24.8% | +54.3% | |
| Q1 2016 | +4.0% | +4.0% | +16.6% | |
| Q4 2015 | +0.8% | — | — | |
| Q3 2015 | -1.8% | — | — | |
| Q2 2015 | +7.5% | — | — | |
| Q1 2015 | -0.7% | — | — | |
| Q4 2014 | +0.8% | — | — | |
| Q3 2014 | -2.5% | — | — | |
| Q2 2014 | -5.5% | — | — | |
| Q1 2014 | -0.4% | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — | |
| Q2 2012 | — | — | — | |
| Q1 2012 | — | — | — | |
| Q4 2011 | — | — | — | |
| Q3 2011 | — | — | — | |
| Q2 2011 | — | — | — | |
| Q1 2011 | — | — | — | |
| Q4 2010 | — | — | — | |
| Q3 2010 | — | — | — | |
| Q2 2010 | — | — | — | |
| Q1 2010 | — | — | — | |
| Q4 2009 | — | — | — | |
| Q3 2009 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro